Kathleen Price, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1065 Bucks Lake Rd, Quincy, CA 95971 Phone: 530-283-7161 Fax: 530-283-7953 |
Elizabeth Mcgee, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1065 Bucks Lake Rd, Quincy, CA 95971 Phone: 530-283-7161 Fax: 530-283-7953 |
Laura Marie Lazenby, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1065 Bucks Lake Rd, Quincy, CA 95971 Phone: 530-283-7161 Fax: 530-283-7953 |
Candice Coursey, NP Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 1065 Bucks Lake Rd, Quincy, CA 95971 Phone: 530-283-2121 Fax: 530-283-7953 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Committee for Medicinal Products for Human Use has adopted a Positive Opinion recommending marketing authorization of patisiran for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
A drug, which reduces insulin resistance and also may have anti-inflammatory and other effects on blood vessels, lowered cardiovascular risk factors in patients with diabetes more than another diabetes medicine, even though both drugs improved blood sugar control equally, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.
Prostate cancer is one of the most common forms of cancer in men and the leading cause of cancer deaths in white, African-American and Hispanic men, according to the Centers for Disease Control. Current treatment of prostate cancer targets androgens, hormones which promote the growth and spread of cancer cells.
The continued drop in overall cancer mortality rates over the last 20 years has averted more than three-quarters of a million (767,000) cancer deaths according to a new report from the American Cancer Society. The American Cancer Society's annual Cancer Statistics article reports that the overall death rate from cancer in the United States in 2007 was 178.4 per 100,000, a relative decrease of 1.3 percent from 2006, when the rate was 180.7 per 100,000, continuing a trend that began in 1991 for men and 1992 for women.
› Verified 9 days ago